Unexpectedly, either Akt activation or FOXO inhibition induce apoptosis and promote myeloid differentiation of AML cells, reverting the established paradigm of Akt behaving as an oncogene, and FOXOs as tumor suppressors. This evidence concerns the gene AKT1 and acute myeloid leukemia.